- Previous Close
0.0450 - Open
0.0467 - Bid --
- Ask --
- Day's Range
0.0410 - 0.0484 - 52 Week Range
0.0330 - 3.8500 - Volume
96,456,984 - Avg. Volume
15,673,401 - Market Cap (intraday)
977,929 - Beta (5Y Monthly) 0.40
- PE Ratio (TTM)
-- - EPS (TTM)
-2.4000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.30
Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
www.aclarion.com4
Full Time Employees
December 31
Fiscal Year Ends
Healthcare
Sector
Health Information Services
Industry
Recent News: ACON
View MorePerformance Overview: ACON
Trailing total returns as of 2025-01-17, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ACON
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ACON
View MoreValuation Measures
Market Cap
977.93k
Enterprise Value
582.33k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.10
Price/Book (mrq)
0.39
Enterprise Value/Revenue
11.81
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-115.33%
Return on Equity (ttm)
-714.18%
Revenue (ttm)
53.95k
Net Income Avi to Common (ttm)
-5.9M
Diluted EPS (ttm)
-2.4000
Balance Sheet and Cash Flow
Total Cash (mrq)
1.22M
Total Debt/Equity (mrq)
47.32%
Levered Free Cash Flow (ttm)
-3.94M
Research Analysis: ACON
View MoreCompany Insights: ACON
ACON does not have Company Insights